DKSH Healthcare has entered a partnership with Renata PLC to bring necessary medication, including pharmaceuticals for the gastrointestinal tract, diabetes, and cardio-dyslipidemia, as well as antibiotics, pain-anti-inflammatory, and antifibrotic treatments to patients in Cambodia.
Cambodia, Phnom Penh, May 12, 2025 - DKSH Business Unit Healthcare, a strategic partner for healthcare companies seeking to grow their business in Asia and beyond, has signed an agreement with Renata PLC, one of the largest and fastest growing pharmaceutical companies in Bangladesh. As part of the partnership, DKSH will expand Renata’s products including Gastrointestinal Tract, Diabetes, Cardio-Dyslipidaemia, ATB (Antibiotic), Pain-Anti-inflammatory, and Antifibrotic medicines to the Cambodian market.
DKSH Cambodia’s experienced teams and broad distribution network will ensure that Renata’s prod-ucts reach modern and traditional trade, hospitals, clinics, other medical channels, and patients in need nationwide.
Ananta Saha, Head of International Business, Renata PLC, commented: “We are delighted to partner with DKSH to bring our high-quality medication to patients in Cambodia. We are confident in DKSH’s strong nationwide footprint, extensive distribution network, and expertise to further strengthen Renata’s brands and growth in this market.”.
Philip Wray, Vice President of Healthcare at DKSH Cambodia, said: “We are proud to be the trusted and strategic partner of Renata. Through this partnership, we will deliver high-quality medications, aim-ing at enhancing patient outcomes across the Cambodian market. This collaboration underscores our commitment to improving health and quality of life for patients, in alignment with DKSH’s purpose of enriching people’s lives by providing healthcare for all.”.
About Renata
Renata PLC is a publicity listed company and one of the largest and fastest growing pharmaceutical companies in Bangladesh, having two direct subsidiaries in UK and Ireland. The core businesses include human pharmaceuticals and animal health products. At present Renata is present in 58 countries through partnerships and we aim to be one of the largest global players in the pharmaceutical sector. www.renata-ltd.com
About DKSH
For 160 years, DKSH has been delivering growth for companies in Asia and beyond across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services, following its purpose of enriching people’s lives. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 28,060 specialists, generating net sales of CHF 11.1 billion in 2024. DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health, over-the-counter products and medical devices. With around 7,940 specialists, the Business Unit generated net sales of CHF 5.7 billion in 2024 www.dksh.com/hec